# PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care

> **NCT00523107** · PHASE2,PHASE3 · COMPLETED · sponsor: **PhytoHealth Corporation** · enrollment: 91 (actual)

## Conditions studied

- Fatigue

## Interventions

- **DRUG:** PG2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00523107
- **Lead sponsor:** PhytoHealth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-04
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523107, "PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00523107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*